Dermovate

Medicinal product

(Invented) name

Dermovate

Active substance (s)

Klobetazolio propionatas

Strength

0,5 mg/g

Pharmaceutical form

kremas

Route (s) of administration

vartoti ant odos

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D07AD01, Clobetasol

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2022-04-13

Date of renewal

Documents

1680_Dermovate_2023-06-26_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 g kremo yra	1 g
Klobetazolio propionatas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108498	94602	1094602	tūbelė	25 g N1		Receptinis	LT/L/22/1680/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-04-13	Registruotas